US0003802040 - ADR
ABCAM PLC-SPON ADR
NASDAQ:ABCM (12/5/2023, 7:00:00 PM)
After market: 23.99 0 (0%)23.99
+0.01 (+0.04%)
Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. The company is headquartered in Cambridge, Cambridgeshire and currently employs 1,750 full-time employees. The company went IPO on 2005-11-03. The firm is engaged in the identification, development and distribution of biological reagents. The Company’s products are used by various researchers worldwide to study biological pathways critical for scientific research, diagnostics and drug discovery. Its products can be grouped into two categories: research use only (RUO) proteomic tools and antibodies for clinical application. RUO products include protein binding reagents, such as antibodies and immunoassays, and related reagents. Its RUO products are used to detect, quantify, visualize and modify proteins in scientific research experiments, serving as vital tools to enable its customers to develop insights about targets and biological pathways of interest. Antibodies are a core component of many in vitro diagnostic assays and can also be used as therapeutic agents to treat various diseases, including cancer.
ABCAM PLC-SPON ADR
Discovery Drive, Cambridge Biomedical Campus, Hills Road
Cambridge CAMBRIDGESHIRE CB2 0AX
P: 441223696000.0
CEO: Alan Hirzel
Employees: 1750
Website: http://www.abcam.com/
/PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The...
Abcam stock surged 3.7% as the company secured regulatory approvals for its $5.7 billion acquisition deal with Danaher.
Abcam stock surged 3.7% as the company secured regulatory approvals for its $5.7 billion acquisition deal with Danaher.
China approves Danaher's $5.7 billion acquisition of Abcam, sending the stock up 0.6%.
Here you can normally see the latest stock twits on ABCM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: